The crosstalk between Wnt/β-catenin signaling pathway with DNA damage response and oxidative stress: Implications in cancer therapy

DNA Repair

Volumn 51, Issue , 2017, Pages 14-19

  Karimaian, Ansar ^a   Majidinia, Maryam ^b,c   Bannazadeh Baghi, Hossein ^d,e   Yousefi, Bahman ^c,e  

^a BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cancer; DNA damage; DNA repair; Oxidative stress; Wnt

Indexed keywords

BETA CATENIN; WNT PROTEIN;

CANCER THERAPY; DNA DAMAGE RESPONSE; HUMAN; MALIGNANT NEOPLASM; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; WNT SIGNALING PATHWAY; ANIMAL; DNA DAMAGE; DNA REPAIR; NEOPLASMS;

ANIMALS; DNA DAMAGE; DNA REPAIR; HUMANS; NEOPLASMS; OXIDATIVE STRESS; WNT SIGNALING PATHWAY;

EID: 85009769627     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2017.01.003     Document Type: Review

References (55)

1. [1] Strzyz, P., DNA damage response: cell thriving despite DNA damage. Nat. Rev. Mol. Cell Biol., 17(7), 2016, 396.
2. [2] Strzyz, P., DNA damage response: controlling ubiquitylation at DNA lesions. Nat. Rev. Mol. Cell Biol., 17(6), 2016, 329.
3. [3] Pearl, L.H., Schierz, A.C., Ward, S.E., Al-Lazikani, B., Pearl, F.M., Therapeutic opportunities within the DNA damage response. Nat. Rev. Cancer 15:3 (2015), 166–180.
4. [4] Goldstein, M., Kastan, M.B., The DNA damage response: implications for tumor responses to radiation and chemotherapy. Annu. Rev. Med. 66 (2015), 129–143.
5. [5] Majidinia, M., Yousefi, B., DNA damage response regulation by MicroRNAs as a therapeutic target in cancer. DNA Repair 47 (2016), 1–11.
6. [6] Schieber, M., Chandel, N.S., ROS function in redox signaling and oxidative stress. Curr. Biol. 24:10 (2014), R453–R462.
7. [7] Shiloh, Y., Ziv, Y., The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nat. Rev. Mol. Cell Biol. 14:4 (2013), 197–210.
8. [8] Davies, K.J., Oxidative Damage & Repair: Chemical, Biological and Medical Aspects. 2013, Elsevier.
9. [9] Zhang, D-y, Pan, Y., Zhang, C., Yan, B-x, Yu, S-s, Wu, D-l, et al. Wnt/β-catenin signaling induces the aging of mesenchymal stem cells through promoting the ROS production. Mol. Cell. Biochem. 374:1–2 (2013), 13–20.
10. [10] Katoh, M., Katoh, M., WNT signaling pathway and stem cell signaling network. Clin. Cancer Res. 13:14 (2007), 4042–4045.
11. [11] Duchartre, Y., Kim, Y.-M., Kahn, M., The Wnt signaling pathway in cancer. Crit. Rev. Oncol. Hematol. 99 (2016), 141–149.
12. [12] Gordon, M.D., Nusse, R., Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J. Biol. Chem. 281:32 (2006), 22429–22433.
13. [13] Wallingford, J.B., Habas, R., The developmental biology of Dishevelled: an enigmatic protein governing cell fate and cell polarity. Development 132:20 (2005), 4421–4436.
14. [14] Majidinia, M., Yousefi, B., Breast tumor stroma: a driving force in the development of resistance to therapies. Chem. Biol. Drug Des., 2017, 10.1111/cbdd.12893 Jan 2. [Epub ahead of print].
15. [15] Komiya, Y., Habas, R., Wnt signal transduction pathways. Organogenesis 4:2 (2008), 68–75.
16. [16] Sirbu, B.M., Cortez, D., DNA damage response: three levels of DNA repair regulation. Cold Spring Harbor Perspect. Biol., 5(8), 2013, a012724.
17. [17] Rupnik, A., Lowndes, N.F., Grenon, M., MRN and the race to the break. Chromosoma 119:2 (2010), 115–135.
18. [18] Yousefi, B., Samadi, N., Ahmadi, Y., Akt and p53R2, partners that dictate the progression and invasiveness of cancer. DNA Repair 22 (2016), 24–29.
19. [19] Bakkenist, C.J., Kastan, M.B., DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421:6922 (2003), 499–506.
20. [20] Warmerdam, D.O., Kanaar, R., Smits, V.A., Differential dynamics of ATR-mediated checkpoint regulators. J. Nucleic Acids, 2010, 2010.
21. [21] Jackson, S.P., Bartek, J., The DNA-damage response in human biology and disease. Nature 461:7267 (2009), 1071–1078.
22. [22] Rogakou, E.P., Pilch, D.R., Orr, A.H., Ivanova, V.S., Bonner, W.M., DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273:10 (1998), 5858–5868.
23. [23] Sørensen, C.S., Syljuåsen, R.G., Safeguarding genome integrity: the checkpoint kinases ATR, CHK1 and WEE1 restrain CDK activity during normal DNA replication. Nucleic Acids Res. 40:2 (2012), 477–486.
24. [24] Yousefi, B., Rahmati, M., Ahmadi, Y., The roles of p53R2 in cancer progression based on the new function of mutant p53 and cytoplasmic p21. Life Sci. 99:1 (2016), 14–17.
25. [25] Shieh, S.-Y., Ikeda, M., Taya, Y., Prives, C., DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91:3 (1997), 325–334.
26. [26] Karimian, A., Ahmadi, Y., Yousefi, B., Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage. DNA Repair 42 (2016), 63–71.
27. [27] Matsuzawa, S-i., Reed, J.C., Siah-1, SIP, and Ebi collaborate in a novel pathway for β-catenin degradation linked to p53 responses. Mol. Cell 7:5 (2001), 915–926.
28. [28] Oren, M., Damalas, A., Gottlieb, T., Michael, D., Taplick, J., LEAL, J.F., et al. Regulation of p53. Ann. N. Y. Acad. Sci. 973:1 (2002), 374–383.
29. [29] Zhang, D-y, Wangj, H-j, H-j, Wang, Wnt/β-catenin signaling induces the aging of mesenchymal stem cells though the DNA damage response and the p53/p21 pathway. PLoS One, 6(6), 2011, e21397.
30. [30] Watcharasit, P., Bijur, G.N., Zmijewski, J.W., Song, L., Zmijewska, A., Chen, X., et al. Direct, activating interaction between glycogen synthase kinase-3β and p53 after DNA damage. Proc. Natl. Acad. Sci. 99:12 (2002), 7951–7955.
31. [31] Busino, L., Donzelli, M., Chiesa, M., Guardavaccaro, D., Ganoth, D., Dorrello, N.V., et al. Degradation of Cdc25A by β-TrCP during S phase and in response to DNA damage. Nature 426:6962 (2003), 87–91.
32. [32] Idogawa, M., Yamada, T., Honda, K., Sato, S., Imai, K., Hirohashi, S., Poly (ADP-ribose) polymerase-1 is a component of the oncogenic T-cell factor-4/β-catenin complex. Gastroenterology 128:7 (2005), 1919–1936.
33. [33] Idogawa, M., Masutani, M., Shitashige, M., Honda, K., Tokino, T., Shinomura, Y., et al. Ku70 and poly (ADP-Ribose) polymerase-1 competitively regulate β-Catenin and T-Cell factor-4–Mediated gene transactivation: possible linkage of DNA damage recognition and wnt signaling. Cancer Res. 67:3 (2007), 911–918.
34. [34] Wang, Y., Sun, Z., Current understanding of klotho. Ageing Res. Rev. 8:1 (2009), 43–51.
35. [35] Liu, H., Fergusson, M.M., Castilho, R.M., Liu, J., Cao, L., Chen, J., et al. Augmented Wnt signaling in a mammalian model of accelerated aging. Science 317:5839 (2007), 803–806.
36. [36] Kops, G.J., Dansen, T.B., Polderman, P.E., Saarloos, I., Wirtz, K.W., Coffer, P.J., et al. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419:6904 (2002), 316–321.
37. [37] Medema, R.H., Kops, G.J., Bos, J.L., Burgering, B.M., AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404:6779 (2000), 782–787.
38. [38] Bowerman, B., Oxidative stress and cancer: a β-catenin convergence. Science 308:5725 (2005), 1119–1120.
39. [39] Chen, J.R., Lazarenko, O.P., Haley, R.L., Blackburn, M.L., Badger, T.M., Ronis, M.J., Ethanol impairs estrogen receptor signaling resulting in accelerated activation of senescence pathways, whereas estradiol attenuates the effects of ethanol in osteoblasts. J. Bone Miner. Res. 24:2 (2009), 221–230.
40. [40] Prockop, D.J., Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:5309 (1997), 71–74.
41. [41] Chen, J.R., Lazarenko, O.P., Shankar, K., Blackburn, M.L., Badger, T.M., Ronis, M.J., A role for ethanol‐induced oxidative stress in controlling lineage commitment of mesenchymal stromal cells through inhibition of Wnt/β‐catenin signaling. J. Bone Miner. Res. 25:5 (2010), 1117–1127.
42. [42] Gao, J., Liu, X., Rigas, B., Nitric oxide-donating aspirin induces apoptosis in human colon cancer cells through induction of oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 102:47 (2005), 17207–17212.
43. [43] Adedara, I.A., Owoeye, O., Aiyegbusi, M.A., Dagunduro, J.O., Daramola, Y.M., Farombi, E.O., Kolaviron protects against benzo [a] pyrene-induced functional alterations along the brain-pituitary-gonadal axis in male rats. Environ. Toxicol. Pharmacol. 40:2 (2015), 459–470.
44. [44] Ajayi, B.O., Adedara, I.A., Farombi, E.O., Benzo (a) pyrene induces oxidative stress, pro-inflammatory cytokines, expression of nuclear factor-kappa B and deregulation of wnt/beta-catenin signaling in colons of BALB/c mice. Food Chem. Toxicol. 95 (2016), 42–51.
45. [45] Walsh, N.C., Reinwald, S., Manning, C.A., Condon, K.W., Iwata, K., Burr, D.B., et al. Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis. J. Bone Miner. Res. 24:9 (2009), 1572–1585.
46. [46] Almeida, M., Han, L., Ambrogini, E., Weinstein, R.S., Manolagas, S.C., Glucocorticoids and tumor necrosis factor α increase oxidative stress and suppress Wnt protein signaling in osteoblasts. J. Biol. Chem. 286:52 (2011), 44326–44335.
47. [47] Yousefi, B., Zarghami, N., Samadi, N., Majidinia, M., Peroxisome proliferator-activated Receptors and their ligands in cancer drug resistance: opportunity or challenge. Anticancer Agents Med. Chem. 16:12 (2016), 1541–1548.
48. [48] Plas, D.R., Thompson, C.B., Akt-dependent transformation: there is more to growth than just surviving. Oncogene 24:50 (2005), 7435–7442.
49. [49] Covey, T.M., Edes, K., Coombs, G.S., Virshup, D.M., Fitzpatrick, F.A., Alkylation of the tumor suppressor PTEN activates Akt and β-catenin signaling: a mechanism linking inflammation and oxidative stress with cancer. PLoS One, 5(10), 2010, e13545.
50. [50] Blagodatski, A., Poteryaev, D., Katanaev, V.L., Targeting the Wnt pathways for therapies. Mol. Cell. Ther., 2(1), 2014, 1.
51. [51] Ochoa-Hernández, A.B., Juárez-Vázquez, C.I., Reynoso, M.A.R., Barros-Núñez, P., WNT-β-catenin signaling pathway and its relationship with cancer. Circulation 80 (2012), 362–370.
52. [52] Hosoya, N., Miyagawa, K., Targeting DNA damage response in cancer therapy. Cancer Sci. 105:4 (2014), 370–388.
53. [53] Lord, C.J., Ashworth, A., The DNA damage response and cancer therapy. Nature 481:7381 (2012), 287–294.
54. [54] Tao, S., Tang, D., Morita, Y., Sperka, T., Omrani, O., Lechel, A., et al. Wnt activity and basal niche position sensitize intestinal stem and progenitor cells to DNA damage. EMBO J. 34:5 (2015), 624–640.
55. 2-induced decreases in proliferation and differentiation of human periodontal ligament fibroblasts. Mol. Cell. Biochem. 411:1–2 (2016), 83–94.